Maximizing Patient Goal Attainment
mGAME
1 other identifier
interventional
258
1 country
1
Brief Summary
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started May 2023
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2022
CompletedFirst Posted
Study publicly available on registry
December 15, 2022
CompletedStudy Start
First participant enrolled
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 4, 2027
April 1, 2026
March 1, 2026
3 years
December 7, 2022
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
8 Months
Secondary Outcomes (1)
To assess the intervention's ability to improve shared decision making using the collaboRATE measure
8 Months
Study Arms (3)
Goal Attainment Intervention
ACTIVE COMPARATORGoal Development Intervention
ACTIVE COMPARATORGoal Development and Tracking Intervention
ACTIVE COMPARATORInterventions
A Systematic process to help patients create "SMaRT " goals
Setting milestones to allow patients to track their progress towards their developed goal
Eligibility Criteria
You may qualify if:
- Individuals 21 years of age or older
- New patients or existing patients with a new problem that are scheduled to see an orthopaedic surgeon in the Hip and Knee Arthroplasty service for a knee consult.
You may not qualify if:
- Individuals who are unable to consent or complete surveys without assistance
- Non-English speaking
- Patients who are less than 12 months from surgery on the knee they are being evaluated for, less than 6 months from surgery on the spine, or less than 3 months from another knee/hip surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dartmouth-Hitchcock Medical Centerlead
- Medacta USAcollaborator
Study Sites (1)
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin J McGuire, MD
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Section Chief for Center for Pain and Spine, Assistant Professor of Orthopaedics
Study Record Dates
First Submitted
December 7, 2022
First Posted
December 15, 2022
Study Start
May 30, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
February 4, 2027
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share